Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Conditions characterized by persistent brain damage or dysfunction as sequelae of cranial trauma. This disorder may result from diffuse axonal injury; intracranial hemorrhages; brain edema; and other conditions. Clinical features may include dementia; focal neurologic deficits; persistent vegetative state; akinetic mutism; or coma.
Biomarker and diagnostic research for dementia pugilistica has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
6 clinical trials registered, 1 recruiting. Interventions under study include other interventions, drug therapy, and procedural interventions. Pipeline includes 1 PHASE3, 2 NA. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT03724136](https://clinicaltrials.gov/study/NCT03724136) |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 1:09 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study |
NA |
MD Stem Cells |
UNKNOWN |
[NCT03218332](https://clinicaltrials.gov/study/NCT03218332) | Post-Concussion Syndrome in Professional Athletes: A Multidisciplinary Study | — | University Health Network, Toronto | UNKNOWN |
[NCT02795052](https://clinicaltrials.gov/study/NCT02795052) | Neurologic Stem Cell Treatment Study | NA | MD Stem Cells | RECRUITING |
[NCT06254469](https://clinicaltrials.gov/study/NCT06254469) | Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease | PHASE3 | CereMark Pharma, LLC | UNKNOWN |
[NCT07302503](https://clinicaltrials.gov/study/NCT07302503) | Pilot Study Evaluating brainQuant's Ability to Detect Alterations in White Matter in Diffusion MRI, Indicative of Post-traumatic Lesions | — | University Hospital, Strasbourg, France | UNKNOWN |
121 publications have been identified in PubMed for dementia pugilistica. Research spans Basic Science / Preclinical (35%), Review / Meta-Analysis (27%), and Epidemiology / Natural History (16%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 42 | 35% |
Research summaries | 33 | 27% |
Disease patterns and progression | 19 | 16% |
Testing and diagnosis research | 11 | 9% |
Patient case studies | 7 | 6% |
Other research | 5 | 4% |
Clinical study results | 3 | 2% |
New treatment approaches | 1 | 1% |
Garay-Serratos ME (2026). [PMID: 41927812](https://pubmed.ncbi.nlm.nih.gov/41927812/). *Nature reviews. Neurology*. [Other]
Inserra CJ (2026). [PMID: 29262155](https://pubmed.ncbi.nlm.nih.gov/29262155/). *Unknown Journal*. [Other]
Chesters J (2026). [PMID: 41918502](https://pubmed.ncbi.nlm.nih.gov/41918502/). *The Yale journal of biology and medicine*. [Review / Meta-Analysis]
Kumar M (2026). [PMID: 41616780](https://pubmed.ncbi.nlm.nih.gov/41616780/). *Cell*. [Basic Science / Preclinical]
Kanakis D (2026). [PMID: 41828490](https://pubmed.ncbi.nlm.nih.gov/41828490/). *International journal of molecular sciences*. [Clinical Trial Publication]
Munakomi S (2026). [PMID: 31082057](https://pubmed.ncbi.nlm.nih.gov/31082057/). *Unknown Journal*. [Other]
Ginsburg J (2026). [PMID: 32491784](https://pubmed.ncbi.nlm.nih.gov/32491784/). *Unknown Journal*. [Other]
Greene C (2026). [PMID: 41849581](https://pubmed.ncbi.nlm.nih.gov/41849581/). *Science translational medicine*. [Diagnostic / Biomarker]
Mosconi M (2026). [PMID: 41880569](https://pubmed.ncbi.nlm.nih.gov/41880569/). *Proceedings of the National Academy of Sciences of the United States of America*. [Basic Science / Preclinical]
Yang S (2026). [PMID: 41328339](https://pubmed.ncbi.nlm.nih.gov/41328339/). *Theranostics*. [Basic Science / Preclinical]